We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
Cap. Flow
-$2.03B
Cap. Flow %
-2.36%
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$354M
2
VZ icon
Verizon
VZ
+$307M
3
HCA icon
HCA Healthcare
HCA
+$256M
4
MPC icon
Marathon Petroleum
MPC
+$239M
5
CMCSA icon
Comcast
CMCSA
+$231M

Sector Composition

Rank Sector Weight
1 Healthcare 20.11%
2 Technology 18.25%
3 Consumer Discretionary 14.02%
4 Industrials 10.23%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
2151
Rigel Pharmaceuticals
RIGL
$750M
$91K ﹤0.01%
3,939
-2,239
-36% -$63.2K
SB icon
2152
Safe Bulkers
SB
$774M
$91K ﹤0.01%
50,993
-13,362
-21% -$30.2K
ACTG icon
2153
Acacia Research
ACTG
$470M
$90K ﹤0.01%
30,118
-155,411
-84% -$481K
RLH
2154
DELISTED
Red Lions Hotel Corporation
RLH
$89K ﹤0.01%
10,911
BAS
2155
DELISTED
Basis Energy Services, Inc.
BAS
$87K ﹤0.01%
22,662
+6,356
+39% +$46.6K
FRTA
2156
DELISTED
Forterra, Inc
FRTA
$86K ﹤0.01%
+22,783
New +$116K
DRRX
2157
DELISTED
DURECT Corp
DRRX
$83K ﹤0.01%
17,215
-39,563
-70% -$345K
INSY
2158
DELISTED
Insys Therapeutics, Inc.
INSY
$83K ﹤0.01%
+23,680
New +$165K
PEI
2159
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$82K ﹤0.01%
924
-146
-14% -$18.2K
SFS
2160
DELISTED
Smart & Final Stores, Inc.
SFS
$78K ﹤0.01%
+16,517
New +$91.1K
VATE icon
2161
INNOVATE Corp
VATE
$165M
$76K ﹤0.01%
2,886
XXII
2162
22nd Century Group
XXII
$1.48M
0
NBR icon
2163
Nabors Industries
NBR
$1.21B
$72K ﹤0.01%
+723
New +$159K
VNTR
2164
DELISTED
Venator Materials PLC
VNTR
$67K ﹤0.01%
+16,064
New +$104K
QHC
2165
DELISTED
Quorum Health Corporation
QHC
$65K ﹤0.01%
22,441
-14,958
-40% -$62.8K
QQQ icon
2166
Invesco QQQ Trust
QQQ
$484B
$60K ﹤0.01%
27,670
-114,707
-81% -$19.2M
ASC icon
2167
Ardmore Shipping
ASC
$683M
$53K ﹤0.01%
11,360
-24,076
-68% -$150K
EVRI
2168
DELISTED
Everi Holdings
EVRI
$53K ﹤0.01%
10,232
-29,578
-74% -$202K
RAD
2169
DELISTED
Rite Aid Corporation
RAD
$48K ﹤0.01%
3,411
-57,326
-94% -$1.21M
OPK icon
2170
Opko Health
OPK
$1.02B
$47K ﹤0.01%
+15,688
New +$53.2K
SREV
2171
DELISTED
ServiceSource International, Inc.
SREV
$41K ﹤0.01%
38,337
-129,526
-77% -$204K
TNK icon
2172
Teekay Tankers
TNK
$2.68B
$40K ﹤0.01%
+5,342
New +$45.8K
MTL
2173
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$21K ﹤0.01%
10,714
+504
+5% +$1.36K
AVEO
2174
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$18K ﹤0.01%
1,126
-6,585
-85% -$145K
OBE
2175
Obsidian Energy
OBE
$662M
$13K ﹤0.01%
4,678
+2,179
+87% +$9.64K

Similar funds

AQR Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
  • AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
  • AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
  • AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
  • AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
  • AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
  • AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.

Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.